Clinically, high levels of BGN were independent of the Lauren classification (Figure 1D and Figure S2D) and the TCGA molecular subtypes (Figure S2E), but it was associated with the more aggressive tumor stages (Figure 1E and Figure S2F,G). Here, BGN is linked to neoplasm.